Frontlight ResearchEarly access
Trial site
Nucleo de Pesquisa Clínica do Rio Grande do Sul
- 12running trials
- 6closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Obesity10 trials
- Type 2 diabetes6 trials
- Chronic kidney disease3 trials
- Obstructive sleep apnoea3 trials
- Alzheimer disease2 trials
- Heart failure2 trials
- Stroke2 trials
- Coronary artery disease1 trial
- Crohn's disease1 trial
- Familial hypercholesterolaemia1 trial
- Lupus (SLE)1 trial
- Peripheral artery disease1 trial
- and 1 more
- Phase
- Phase 315 trials
- Phase 2/33 trials
- Phase 21 trial
- Status
- Active, not recruiting5 trials
- Completed5 trials
- Recruiting4 trials
- Not yet recruiting3 trials
- Suspended1 trial
- Withdrawn1 trial
- Lead sponsor
- Eli Lilly and Company13 trials
- ACADIA Pharmaceuticals Inc.1 trial
- Biogen1 trial
- Bristol-Myers Squibb1 trial
- Crinetics Pharmaceuticals Inc.1 trial
- and 2 more
Running trials
Not yet recruiting
Recruiting
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Recruiting
Recruiting
A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Obesity3 recruiting
- Type 2 diabetes3 recruiting
- Alzheimer disease1 recruiting
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- Stroke1 recruiting
Closed trials
Completed
Recruiting
Completed
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026